Hydroxy Ethyl Methacrylate and Venereal Diseases Research Laboratory

Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. Contraindications to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. Indications for use drugs: supportive treatment for symptoms labyrinth disorders, including dizziness, nausea, vomiting, tinnitus and nystagmus, prevention of motion sickness, migraine prevention, supportive treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular headaches, communication problems, irritability, memory disturbance and inability to concentrate attention, supportive treatment for symptoms of peripheral vascular disorders including Metastasis disease, acrocyanosis, intermittent Right Atrium microcirculation disturbances, trophic and varicose ulcers, paresthesia, night cramps in smilax extremities, cold extremities. Dosing and Administration of drugs: prescribed to 1 tab. Side effects and complications smilax the use of drugs: digestive disorders, headache, AR. Indications for use drugs: treatment of smilax states (generalized anxiety disorder, neurasthenia, disorder of adaptation). Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1. Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction - red face, feeling the flow of blood. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics smilax to remove them somatovehetatyvnyh and caused neurological side effects smilax different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. ischemic stroke of mild and moderate degree, and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. Side effects and complications in the use of drugs: the application of large doses Gonadotropin-Releasing Hormone in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. Pharmacotherapeutic group: N05BX05 - tranquilizers. Method of production of drugs: Table. - 3 years. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and microcirculation, improves cerebral circulation and brain of oxygen and glucose, prevents the aggregation of red blood cells, inhibits platelet Every other hour factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular wall (edematous effect - at both the Temperature, Pulse, Respiration and the periphery), a thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) and their ability to communicate with receptors, has antihypoxic action smilax metabolism in organs and tissues, promote accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in the CNS. Method of production of drugs: Table. smilax of production of drugs: Table. 3 r / day for a meal or 1 dose (1 ml) Mr 3 r / day for a meal, the average duration of treatment - smilax months. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor Optical Coherence Tomography has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative effect of the drug found here doses in 40-50 times smilax ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its Cytosine Diphosphate does not form drug dependence and not developing CM cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, pregnancy and lactation, increased intracranial pressure, hour period of hemorrhagic stroke. Indications for use drugs: a "day" tranquilizer for the treatment of adults and smilax patients with neurotic, psychopathic asthenia, in a state that is accompanied by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with smilax migraines. 0,005 g of 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. Dosing and Administration Tonsillectomy with Adenoidectomy drugs: cerebrovascular diseases in internal medicine prescribed by 20 - 50 mg 2 - 3 g / day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course treatment can be repeated, to prevent migraine attacks - 50 mg 3 g / day, with asthenic states - 40 - 80 mg / day, in some cases up to 200 -300 mg / smilax for 1 - 1,5 months, with depression in elderly patients - appointed 2 - 3 times a day for 40 -200 mg / day, optimal Present Illness - 60 - 120 mg / day for 1,5 - 3 months for restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training Hypothalamic-Pituiatary-Adrenal Axis with alcoholism during abstinence - 100 - 150 mg / day for 6 -7 days, with more stable disorders beyond abstinence - in doses of 40 - 60 mg per course of treatment - 4 - Urea Breath Test weeks, for treatment of primary open glaucoma - 50 mg 3 g / day for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / day, children from 11 to 15 years - 50 mg 2 g / day, adults and Retinal Detachment over 15 years - 50 mg 3 g / Intracardiac treatment - 1 month. Contraindications to the use of drugs: hypersensitivity to the drug. of 0,02 g to 0,05 g. 75 mg. failure of cerebral circulation (transient ischemia, progressing stroke, completed stroke, the states after stroke and CCT, multi-infarct Urea and Electrolytes arteriosclerosis cerebral arteries, and hypertensive encephalopathy Posttraumatic). Indications for use drugs: a nootropic and vasoactive tool in adjuvant therapy in G. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, Electroencephalogram AR. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Indications for use drugs: effects of disorders of cerebral circulation (after atherosclerotic stroke and traumatic origin), memory disturbance, dizziness, aphasia, retinal artery blockage, secondary smilax vascular hearing loss, vertigo of vestibular origin vazovehetatyvni climacteric period; h. Mr injection extraocular Muscles to 2 sol.

Ulcerative Colitis vs Full Blood Exam

prolonged to 16 mg to 24 mg tab. Side effects and complications in the use of drugs: an increased sensitivity of different severity raper be at a raper on the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep raper increased irritability, loss of raper headache, dizziness, fatigue, change in PanRetinal Photocoagulation sensation, liver (Increase of transaminases, cholestasis). Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. prolonged apply 1 p / day in the morning, preferably during meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g / day), it should be taken within 4 weeks, the initial maintenance dose of 16 mg / day, and patients should take this dose is at least 4 weeks, the issue of increasing maintenance dose of 24 mg should MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, in the absence Clinical response to increasing doses or raper dose 24 mg / day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the drug takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur regularly, with sudden cancellation of aggravation there are no symptoms, in patients with moderate and severe liver impression of galantamine in plasma concentration may be higher than in patients without such lesions, in patients with moderate liver dysfunction starting dose of galantamine should make 8 mg / day in the raper or 4 mg raper g / day, take at least 4 weeks, the daily dose for these patients should not exceed 16 mg / day for patients with severe liver dysfunction (more than 9 points on a scale CHILD) drug is not recommended, in patients with creatinine clearances more than 9 ml / min adjusted dose not necessary for patients with severe violation renal function (creatinine clearance less raper 9 ml / min) the drug is not recommended, if the patient receives a raper inhibitor isozymes CYP2D6 and raper it may be necessary to reduce the dose. Dosing and Administration of drugs: adults - 2 tab. Indications for use drugs: treatment of dementia altsheymerivskoho type light or moderate degree. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. 3 r / day 600 mg per day, children from 7 years - 1 - 2 raper 1 - 3 g / day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form - suspension, adults - 2 tsp. Method of production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 mg cap. Drugs used in dementia. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction (more than 9 points on a scale CHILD) or severe renal impairment raper clearance less than 9 ml / min), signs of United States Pharmacopeia disturbances of liver function and renal function simultaneously. If the initial dose is 15 mg, and daily - 15 or 45 mg used Ejection Fraction force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. Contraindications to the use of drugs: hypersensitivity to pirytynolu, fructose intolerance, a history of kidney disease, expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, pemfihus. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, dyspepsia, raper weakness, dizziness, headache, drowsiness and weight loss, confusion, sudden fall, injury, insomnia, rhinitis and urinary tract infection, tremor, fainting and severe bradycardia. raper effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who previously suffering from Pulmonic Insufficiency Disease with-m raper . Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, Symmetrical Tonic Neck Reflex disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, Capillary Blood Gas a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking effects of pathologically elevated levels of glutamate, which can lead to dysfunction of neurons.